Nomura Asset Management »

BioMarin Pharmaceutical shares owned by Nomura Asset Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Nomura Asset Management from 13F filings

Historical chart of Nomura Asset Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Nomura Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Nomura Asset Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $623k 10k 62.30

More positions owned by Nomura Asset Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
Applied Materials (AMAT)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Johnson & Johnson (JNJ)
Qualcomm (QCOM)

View all positions for Nomura Asset Management

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical